Thyrotoxicosis.
Franklyn
Jayne
J
Division of Medical Sciences, University of Birmingham, Queen Elizabeth Hospital, Edgbaston.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D013956:Antithyroid Agents / Q000009:adverse effects / Q000627:therapeutic use; D002231:Carbimazole / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006111:Graves Disease / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000532:radiotherapy; D006331:Heart Diseases / Q000209:etiology; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008297:Male; D011193:Potassium Iodide / Q000008:administration & dosage / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011441:Propylthiouracil / Q000008:administration & dosage / Q000627:therapeutic use; D011644:Puerperal Disorders / Q000188:drug therapy; D011879:Radiotherapy Dosage; D013958:Thyroid Crisis / Q000188:drug therapy; D013960:Thyroid Function Tests; D013965:Thyroidectomy; D013971:Thyrotoxicosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000532:radiotherapy; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D013956:Antithyroid Agents; D007457:Iodine Radioisotopes; D011193:Potassium Iodide; D011441:Propylthiouracil; D002231:Carbimazole